Glisolamide

This classification denotes an anti-diabetic agent with the molecular formula C20H26N4O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) F83U6T74XR, chemically known as 3-isozazolecarboxamide, n-(2-(4-((((cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-5-methyl- but more generally known as glisolamide, which bears US NIH Compound Identifier 65713. European Medicines Agency schedules Glisolamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07932MIG. The term GLISOLAMIDE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 34, No. 10 1980, List 20). GLISOLAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule glisolamide under HS 29350090 and SITC 51580. As of Q4 2014, GLISOLAMIDE remains US FDA's Preferred Term for this commodity. Glisolamide bears US NLM identifiers UMLS ID C0061329 and NCI Concept Code C72800. SMILES: S(=O)(=O)(NC(=O)NC1CCCCC1)C1CCC(CCNC(=O)C2NOC(C2)C)CC1.